Paul Wreglesworth

  PhotoPaul Wreglesworth has a BSc (Hons) in pharmacy and has more than 30 years experience in the Pharmaceutical Industry with considerable experience of the development, manufacture and sourcing of pharmaceuticals gained at both local site and corporate level. He is recently retired from AstraZeneca in the UK where he was global technology director with specific responsibility for manufacturing technology strategy. Prior to taking on that role Paul was New Product Director with responsibility for the manufacturing strategy for the Company’s anti-cancer products in which position he developed a particular interest in the handling of hazardous compounds. Paul has been a core member of the team that drafted the ISPE RiskMaPP guideline currently under review by FDA and has spoken extensively on the topic in Europe, North America and Asia.